Live Breaking News & Updates on Andreas Maercker|Page 19
Stay updated with breaking news from Andreas maercker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a research note, Warburg Research analyst Andreas Wolf has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at EUR 52. | April 25, 2023 ....
21st Austria weekly - Marinomed Andritz 19/04/2023 [pic1]Marinomed: Marinomed Biotech AG achieved istable total revenues of € 11.3 m 2021: 11.6 m. Cash and cash equivalents increased by 41% to 8.2 5.8 m due the drawdown last tranche EIB financing cost-conscious liquidity management. Further investments in Marinomed s future growth path were reflected earnings development according plan. Thus research expenses remained at a high level 6.9 2022 7.5 The operating result -4.9 was slightly below prior-year figure -4.1 m. Andreas Grassauer CEO says: "2022 another successful year for Marinomed. Although ....
Already positive, the research from Goldman Sachs and its analyst Andreas Scheriau still consider the stock as a Buy opportunity. No major update to the target price set at EUR 17.60 compared to EUR. | April 20, 2023 ....
Deputy Minister of Foreign Affairs Andreas Katsaniotis’ statement at the “Eleftherios Venizelos” airport upon his return to Athens with the Holy Fire (Athens, 15.04.2023) Announcements - Statements - Speeches Current Affairs ....
Deputy Minister of Foreign Affairs, Andreas Katsaniotis’ reply to H.H.B. the Patriarch of Jerusalem Theophilos III at the ceremony for receiving the Holy Fire (Jerusalem, 15.04.2023) Announcements - Statements - Speeches Current Affairs ....